RTO-MOX 150 LA

Contains per ml:

Amoxycillin base  ………………………………………………………………………………….    150 mg.

Solvents ad……………………………………………………………………………………………….   1 ml.

Gastrointestinal, respiratory and urinary tract infections caused by amoxycillin sensitive micro-organisms, like Campylobacter, Clostridium, Corynebacterium, E. coli, Erysipelothrix, Haemophilus, Pasteurella, Salmonella, penicillinase negative Staphylococcus and Streptococcus spp. in calves, cattle, goats, sheep and swine.

moxycillin is a semisynthetic broad-spectrum penicillin with a bactericidal action against both Gram-positive and Gram-negative bacteria. The range of effect includes Campylobacter, Clostridium, Corynebacterium, E. coli, Erysipelothrix, Haemophilus, Pasteurella, Salmonella, penicillinase negative Staphylococcus and Streptococcus spp. The bactericidal action is due to inhibition of cell wall synthesis. Amoxycillin is mainly excreted in urine. A major part can also be excreted in bile.

Hypersensitivity to amoxycillin.

Administration to animals with a seriously impaired renal function.

Concurrent administration of tetracyclines, chloramphenicol, macrolides and lincosamides.

For intramuscular or subcutaneous administration:

General: 1 ml per 10 kg body weight, repeatable if necessary after 48 hours.

Shake well before use and do not administer more than 20 ml in cattle, more than 10 ml in swine and more than 5 ml in calves, sheep and goats per injection site.

Hypersensitivity reactions.
Packaging:<div id=”after-product-details” class=”after-product-details ic_tabs_container”>
<div id=”product_description” class=”product-description ic_tab_content active”>

Vial of 100 ml and 50 ml.

</div>
</div>
<div class=”after-product-description”>
<div class=”related-products”></div>
</div>